Alexander G. Camenzind
Papers
1
Total Citations
40
H-Index
1
About
Alexander G. Camenzind is a researcher whose work sits at the intersection of analytical chemistry and clinical diagnostics, with a primary focus on advancing mass spectrometry-based methods for hypertension management. His most notable contribution is the development and evaluation of an immuno-MALDI (iMALDI) assay for angiotensin I, a critical tool for measuring plasma renin activity (PRA) in the diagnosis of secondary hypertension. This work, published in 2013 and cited 40 times, directly addressed the limitations of traditional competitive radioimmunoassays—such as non-specificity, lengthy analysis times, and narrow calibration ranges—by offering a more precise, rapid, and specific alternative. Camenzind’s innovation has the potential to streamline screening for secondary forms of hypertension, improving patient outcomes through earlier and more accurate diagnosis. His research exemplifies how integrating immunological capture with MALDI-TOF mass spectrometry can transform clinical laboratory practice, making him a key figure in the ongoing evolution of diagnostic technologies for endocrine disorders.
Research Focus
Key Achievements
Top Papers
- 1